Royce & Associates LP Rvl Pharmaceuticals PLC Transaction History

Royce & Associates LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$2.8 - $3.78 $33,922 - $45,794	-12,115 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$3.26 - $4.84 $39,494 - $58,636	12,115 New	12,115 $39,000
Q3 2020 Nov 12, 2020	SELL	$4.82 - $8.77 $24,157 - $43,955	-5,012 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$2.83 - $6.99 $3,316 - $8,192	-1,172 Reduced 18.95%	5,012 $34,000
Q1 2020 May 12, 2020	BUY	$3.18 - $7.0 $19,665 - $43,288	6,184 New	6,184 $20,000
Q3 2019 Nov 13, 2019	SELL	$2.8 - $3.99 $26,541 - $37,821	-9,479 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$2.34 - $4.28 $22,180 - $40,570	9,479 New	9,479 $36,000
Q1 2019 May 09, 2019	SELL	$3.6 - $8.75 $9,882 - $24,018	-2,745 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$6.25 - $9.2 $17,156 - $25,253	2,745 New	2,745 $21,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.